GetTopicDetailResponse(id=7cbc31942f, topicName=bapineuzumab, introduction=bapineuzumab, content=null, image=null, comments=4, allHits=1127, url=https://h5.medsci.cn/topic?id=3194, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=5582, tagList=[TagDto(tagId=5582, tagName=bapineuzumab)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1929122, encodeId=fd2819291223c, content=<a href='/topic/show?id=7cbc31942f' target=_blank style='color:#2F92EE;'>#bapineuzumab#</a>, objectTitle=Neurology：Bapineuzumab治療導(dǎo)致的淀粉樣蛋白相關(guān)影像學(xué)異常水腫/滲出與腦生物標(biāo)志相關(guān)性研究, objectType=article, longId=128813, objectId=910f1288139c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=910f1288139c, replyNumber=0, likeNumber=85, createdTime=2018-06-11, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=910f1288139c, moduleTitle=Neurology：Bapineuzumab治療導(dǎo)致的淀粉樣蛋白相關(guān)影像學(xué)異常水腫/滲出與腦生物標(biāo)志相關(guān)性研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=910f1288139c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1929121, encodeId=a85d1929121c2, content=<a href='/topic/show?id=7cbc31942f' target=_blank style='color:#2F92EE;'>#bapineuzumab#</a>, objectTitle=NEJM：巴匹珠單抗（bapineuzumab ）用于輕中度老年性癡呆治療失敗, objectType=article, longId=30201, objectId=e2313020144, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2313020144, replyNumber=0, likeNumber=93, createdTime=2014-12-20, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2313020144, moduleTitle=NEJM：巴匹珠單抗（bapineuzumab ）用于輕中度老年性癡呆治療失敗, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e2313020144)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1929120, encodeId=b8941929120c3, content=<a href='/topic/show?id=7cbc31942f' target=_blank style='color:#2F92EE;'>#bapineuzumab#</a>, objectTitle=輝瑞放棄對阿爾茨海默病藥物Bapineuzumab的研究, objectType=article, longId=8792, objectId=3b1a8e92d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b1a8e92d7, replyNumber=0, likeNumber=75, createdTime=2013-01-16, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b1a8e92d7, moduleTitle=輝瑞放棄對阿爾茨海默病藥物Bapineuzumab的研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3b1a8e92d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1929119, encodeId=5a75192911972, content=<a href='/topic/show?id=7cbc31942f' target=_blank style='color:#2F92EE;'>#bapineuzumab#</a>, objectTitle=輝瑞及強(qiáng)生bapineuzumab阿爾茨海默氏癥項(xiàng)目III期試驗(yàn)失敗, objectType=article, longId=8429, objectId=4e8c842994, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e8c842994, replyNumber=0, likeNumber=95, createdTime=2012-11-16, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e8c842994, moduleTitle=輝瑞及強(qiáng)生bapineuzumab阿爾茨海默氏癥項(xiàng)目III期試驗(yàn)失敗, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4e8c842994)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
